Latest filing published 10 Nov 2009 for JUNIPER PHARMACEUTICALS INC, €29k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lawrence A. Gyenes: trading record in brief
Lawrence A. Gyenes discloses dealings in 2 companies, chiefly Juniper Pharmaceuticals Inc and Zila Inc. Between 12 March 2007 and 9 November 2009, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 1 purchase, €29k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. In 2009 alone, the filings show 1 purchase and no sales.
Most recently, on 10 November 2009, the filings show an open-market purchase worth €29k in Juniper Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lawrence A. Gyenes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$0.8657$.01 Per Value Common StockSEC:0001140361-09-025336:0Canonical exit: 7 Feb 2010 (T+90)
- 50,000 shares0Common StockSEC:0001341522-07-000007:0
2 of 2 declarations